ART Market Analysis
Based on type, the market is bifurcated into product and procedure. The procedure segment is estimated to account for USD 58.6 billion by 2032.
- The prevalence of infertility is increasing globally due to various factors such as lifestyle changes, environmental factors, and delaying childbirth. As a result, more individuals and couples are seeking fertility treatments, fertility supplements, and adopting ART procedures, to achieve their goal of parenthood.
- It encompasses various assisted reproductive technology (ART) procedures such as in vitro fertilization (IVF) and artificial insemination. Increasing number of in-vitro fertilization increases the adoption rate of assisted reproductive technology.
- For instance, according to the Japan Society of Obstetrics and Gynecology, in 2021, the number of children born through in vitro fertilization as part of infertility treatment increased by 9,416 from the previous year to a record high of 69,797 in Japan. Furthermore, the most common age for those receiving treatment was 39, with 39,631 cases, followed by those aged 40 and 41.
- Continuous advancements in ART technologies and techniques have significantly improved success rates and outcomes of procedures. Innovations such as time-lapse imaging, preimplantation genetic testing, and embryo vitrification have enhanced the efficacy and safety of ART procedures, leading to increased adoption and demand.
Based on end-user/provider, the assisted reproductive technology market is divided into hospitals, fertility clinics, and other end-users/providers. The fertility clinics segment accounted for USD 18.8 billion in 2023.
- These clinics are dedicated to reproductive medicine and have specialized expertise in diagnosing and treating infertility. They employ reproductive endocrinologists, fertility specialists, embryologists, and other healthcare professionals who are trained and experienced in ART procedures.
- Increase in fertility clinics is a significant driver for the market leading to increased uptake of ART among the patients.
- According to the National Institutes of Health, in 2023, India is witnessing a surge in IVF clinics and chains, with an estimated 2500 clinics functional across India.
- Further, according to the National Library of Medicine, in 2021, a total of 601 fertility clinics in Japan performed treatments of assisted reproductive technology (ART). Thus, such aforementioned factors are expected to augment the segmental growth.
U.S. assisted reproductive technology market is anticipated to grow at CAGR of 6.5% during the analysis timeframe.
- Increasing percentage of IVF delivery rate/cycle in the US further attracts a major pool of patients to adopt the ART procedures, thereby escalating the growth of the market.
- According to the Centers for Disease Control and Prevention, in 2021, 86,146 infants born (or 2.3% of all infants born in the U.S.) were conceived through the use of ART in the U.S. IVF enables individuals who use fertility preservation services to save their eggs, sperm, or reproductive tissues to have children at a later time.
Germany assisted reproductive technology (ART) market is anticipated to witness lucrative growth between 2024 – 2032.
- The country has witnessed a growing demand for ART services due to factors such as delayed childbearing, rising infertility rates, and increased awareness about assisted reproductive technologies.
- The trend of postponing parenting for career goals and financial stability has led to an increased reliance on ART services in the country.
Japan assisted reproductive technology market is expected to grow significantly over the years.
- Japan is known for its technological innovation across various industries, including healthcare. Japanese companies have developed advanced ART technologies and equipment, making them a preferred choice for patients seeking fertility treatments.
- Similar to many developed countries, Japan has an aging population and declining birth rates. This demographic trend has led to an increase in demand for ART services among couples facing infertility issues or delaying parenthood.
South Africa ART market is anticipated to witness lucrative growth between 2024 – 2032.
- South Africa government has implemented regulations to govern the practice of ART and ensure the safety and quality of fertility treatments. Additionally, the government provides support in terms of infrastructure development and funding for research and development in the field of reproductive medicine.